鉴定tau的趋于聚合的结构
Shana Elbaum-Garfinkle1, Elizabeth Rhoades
1Department of Molecular Biophysics and Biochemistry, Yale University, 266 Whitney Avenue, New Haven, Connecticut 06520-8114, USA.
Journal of the American Chemical Society
|September 25, 2012
概括
研究人员研究了蛋白聚合,这是阿尔茨海默病的关键因素. 他们确定了在聚合之前出现的特定tau结构,为神经退行性疾病提供了潜在的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 结构生物学 结构生物学
背景情况:
- 蛋白质聚合是神经退行性疾病的核心,如阿尔茨海默病和帕金森病.
- 鉴定等内在无序蛋白质的结构变化具有挑战性,但对于理解疾病机制至关重要.
- 陶蛋白错误折叠和聚合成纤维是阿尔茨海默病病理学的标志.
研究的目的:
- 使用单分子Förster共振能量转移 (smFRET) 调查陶蛋白的结构组合.
- 为了确定与蛋白质聚合的启动相关的tau中的关键形状变化.
- 探索肝素结合对形状及其在聚合中的潜在作用的影响.
主要方法:
- 单分子Förster共振能量转移 (smFRET) 用于测量蛋白形状.
- 在没有和存在肝素的情况下,分析了的构造组合.
- 对的不同领域进行了检查,以检查它们的特定形状特性和障碍水平.
主要成果:
- 的不同领域表现出独特的形状特征,与它们的内在障碍程度相关.
- 氨酸结合会诱导中显著的两种状态结构过渡.
- 这种过渡涉及到远距离接触的丧失和tau的微管结域的紧缩.
结论:
- 已经确定了一种特定的tau conformational中间体,先于聚合物形成.
- 这种中间体代表了开发对相关神经退行性疾病的治疗方法的潜在治疗目标.
- 了解的结构动力学是解开它在神经退行症中的作用的关键.
相关概念视频
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...


